MILWAUKEE, WI–(Marketwire – July 13, 2010) –  CPI has released a new company logo and website. The new crisisprevention.com consolidates all CPI websites, including preparetraining.com, dementiacarespecialists.com, and iancici.org, into a single enhanced and redesigned site.

Based on customer and Certified Instructor feedback, crisisprevention.com is completely revamped to include more intuitive navigation, improved account management, and an enhanced online shopping experience. It also includes a new documentation feature, which allows Certified Instructors to submit training documentation online.

The company logo has been redesigned to reflect the CPI mission and values. The logo shows people reaching out to each other with their hands, symbolizing the integral relationship between CPI and its Certified Instructors in their mission to educate, empower, and enrich the lives of others. Individual logos for each CPI specialized offering — Nonviolent Crisis Intervention^® training, Prepare Training^® program, and Dementia Care Specialists — have also been updated with a fresh, coordinated look.

According to Tony Jace, CPI chief executive officer, the new logos and website mirror the company’s commitments to expand the message of care and well-being.

“We value our commitment to increase the effectiveness of our Certified Instructors as they manage their day-to-day interactions and responsibilities. Through our new look and improved tools, we continue to provide individuals and organizations the resources they need to create safer, enriched environments,” he said.

CPI, headquartered in Milwaukee, WI, is the world’s leading training organization specializing in the safe management of disruptive and assaultive behavior. CPI’s cornerstone Nonviolent Crisis Intervention^® training and Prepare Training® programs focus on workplace violence prevention and offer effective strategies for managing anxious, hostile, or violent behavior. Through Dementia Care Specialists, CPI also offers dementia care training to improve function, safety, and quality of life. Since 1980, more than 6 million professionals have participated in CPI training, and thousands of organizations worldwide have successfully implemented CPI’s unique behavior management techniques.

AKRON, OH–(Marketwire – July 13, 2010) –  Hospitals can gain significant revenue by improving documentation of services and procedures and instituting better material management practices.

That’s the counsel from Ryerson Healthcare Consultants, medical revenue specialists and the nation’s leader in emergency department process improvement. The Ryerson organization serves clients with hospital charge capture experience gained through working with more than 540 hospitals in 40 states.

Whether they are working on clients’ surgical services or emergency department charge capture, Ryerson’s experts tailor improvement recommendations to fit each hospital’s specific challenges.

“OR and ED operations are uniquely complex, and staff in both areas tend to experience problems in properly documenting, coding and billing for all chargeable procedures and supplies,” said President Peter Ryerson. “Our team of hospital charge capture specialists includes people who have considerable experience as RNs in both areas, with track records of success in successfully improving their client hospitals’ revenues.”

Such experience and knowledge is invaluable for hospital charge capture improvement, the goal for the majority of Ryerson Healthcare Consultants’ clients. Ryerson said his team develops solutions that result in improvements to the charge protocol and hospital charge capture process.

“In many, if not most, cases, it comes down to strengthening our clients’ documentation and billing processes,” Ryerson said. “We find that many hospitals lack the tools and information necessary to properly document, code and bill. The obvious result is billing that fails to capture all of the services that are rendered.”

He said refining the documentation and charge processes and training managers and staff in the proper procedures can result in significant gains in both OR and ED charge capture. In many cases, such gains can transform a money-losing surgical services or emergency department into a reliable profit center. 

Ryerson’s team also works on strengthening material management procedures. Relying on time-proven protocols, Ryerson develops best-practice material management processes and helps its client hospitals institute them. Ryerson also guides training of staff and managers in the value of remaining in compliance with the procedures.

“We also find that improving communication between the financial managers and the clinical staff pays great dividends,” he said. “When the financial people and clinicians understand each other’s roles in achieving profitability, we see time after time that this enhances the hospital’s ability to effectively cost and bill for provided services.”

Click here to see all recent news from this company

CHARLOTTE, NC–(Marketwire – July 13, 2010) –  Patient Care Technology Systems (PCTS), a subsidiary of Consulier Engineering, Inc. (NASDAQ: CSLR), today announced that Providence Willamette Falls Medical Center will add Amelior ORTracker® — a web-based workflow visibility and automation solution built to streamline patient flow and improve efficiency — in their Oregon City, OR Surgical Services Department. 

Providence Willamette Falls Medical Center is a 143-bed healthcare facility serving the Portland area since 1954. In October 2009, Willamette Falls Hospital officially became Providence Willamette Falls Medical Center when it joined the Providence Health and Services family.

The installation, expected to be complete by the fourth quarter 2010, will include the solution Amelior ORTracker — part of the Amelior Enterprise Visibility and Workflow Automation Suite™ which comprises department to facility-wide software solutions and services designed to more efficiently and safely orchestrate patient care through the real-time visualization of patient flow. Hospitals can scale their implementations by the entities they wish to track (patients, staff, movable medical equipment), purpose (patient flow, temperature monitoring, asset management, infection control) and by the scope of hospital workflow (surgical services, acute care, inpatient floors, outpatient services, enterprise-wide).

With the Amelior ORTracker system, Providence Willamette Falls can monitor, in real-time, the status of patients as they travel through the perioperative process from pre-op, inter-op, PACU (post anesthesia care unit) and post-op. They will have access to computer watch lists that will provide a comprehensive view of the cases for the day, including real-time patient and staff status and location. 

Providence Willamette Falls will join its “sister” facilities Providence Portland Medical Center and Providence St. Vincent Medical Center, which have been using Amelior ORTracker since 2003. In the last seven years, these facilities have seen a reduced time waiting between stages of care in a perioperative visit, enabling them to add-on cases and effectively increase departmental capacity; provided a quieter, more healing environment by decreasing the need for overhead pages and phone calls; and improved safety through the automatic tracking of key intervals such as the administration of antibiotics.

“It’s Providence’s goal to continue to provide the best care possible in all the communities we serve. This includes providing a consistent platform for patient and staff satisfaction,” said Deborah Tuke Bahlman, Providence Health & Services – Oregon Regional IT Director of Surgical Services. 

Tony Marsico, president and chief executive officer for PCTS says, “We have a long history of partnering with Providence, and we welcome the opportunity to implement Amelior ORTracker in another PH&S facility. Providence again shows their continued dedication to their community.”

PCTS has expanded their Amelior Enterprise Visibility and Workflow Automation Suite into other departments within the Providence Health and Services community in Oregon, including the Providence Heart and Vascular Institute and the radiology department at Providence St. Vincent.

About Providence Willamette Falls Medical Center
Providence Willamette Falls Medical Center is a not-for-profit acute care hospital operated by Providence Health & Services in Oregon City, OR. Established in 1954 as Doctors’ Hospital, the hospital moved to its current location in 1961 and has 143 licensed beds at its 243,000-square-foot (22,600 m²) facility. Providence Willamette Falls also operates several medical offices and clinics outside of Oregon City in other parts of Clackamas County. Previously known as Willamette Falls Hospital, the hospital merged with Providence in 2009.

About Patient Care Technology Systems
Patient Care Technology Systems, a subsidiary of Consulier Engineering, Inc. (NASDAQ: CSLR), helps health care providers to improve patient flow, increase capacity and improve patient and staff safety by visualizing the real-time location and status of people and equipment throughout their facility. PCTS solutions have supported over 2 million patient visits annually and have shown a proven return on investment in high turnover, high-acuity units such as the emergency department and perioperative suites. The Amelior Enterprise Visibility and Workflow Automation Suite™ is interoperable with all leading locating technologies, including active-RFID, infrared, ultrasound, ultra-wideband, Wi-Fi and ZigBee. PCTS customers have been recognized nationally for improvements in efficiency and clinical excellence. For more information, visit www.pcts.com. 

This press release contains forward-looking statements within the meaning of federal securities laws. PCTS and CSLR caution you that any statements contained in this press release which are not strictly historical statements constitute forward-looking statements. Such forward-looking statements include, but are not limited to, those related to PCTS’s and CSLR’s expectations regarding continued business growth. These statements are neither promises nor guarantees, and involve risks and uncertainties that could cause actual results to differ materially from such forward-looking statements, (copies of which may be obtained at the SEC’s website at: http://www.sec.gov) — could impact the forward-looking statements contained in this press release. Readers should not place undue reliance on any such forward-looking statements, which speak only as of the date they are made. PCTS and CSLR disclaim any obligation to publicly update or revise any such statements to reflect any change in PCTS and CSLR’s expectations, or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.

Click here to see all recent news from this company

ANDOVER, MA–(Marketwire – July 13, 2010) –  Capsule, the leading provider of medical device connectivity, announced that they will be hosting a webinar on July 21, 2010 at 1:00pm Eastern Time on a number of issues hospitals are facing in reaching meaningful use criteria outlined in the HITECH provision of the ARRA. Featured in the webinar will be how medical device integration improves patient care and safety and helps meet Phase I, II and III meaningful use criteria including CPOE.

Ann Farrell, Principal at Farrell Associates, and Kevin Phillips, Partner Development Manager at Capsule, will engage in an interactive discussion about medical device integration and meaningful use. They will discuss why it is critical that real time data be available when hospitals are implementing CPOE technology. They will also discuss how medical device integration can affect the entire enterprise and help meet a number of patient care and safety goals and why it therefore should be placed on a hospital’s short term priority list.

Key topics that will be discussed include: the real benefits of medical device integration, how device integration can recover nursing hours, how can it improve overall patient care and safety, how it addresses hospitals’ key issues surrounding clinical workflow and CPOE, and how device integration can help meet Phases 1, 2 and 3 meaningful use criteria as outlined in the HITECH provision of the ARRA. The speakers are also encouraging participants to submit individual questions prior to the webinar by filling out a form on the registration page. For more information and to register and submit your questions right away click here: https://www1.gotomeeting.com/register/614983312

About Capsule’s Enterprise Device Connectivity Solution™
Capsule’s Enterprise Device Connectivity Solution is the only solution that will truly adapt to the environment it operates in. Its design gives hospitals the option to deploy connectivity throughout the enterprise so that all departments, not just high acuity, can enjoy the value that device integration has to offer. And it completely integrates with existing or planned caregiver work processes and allows a facility to leverage existing technologies. For more information about Capsule’s Enterprise Device Connectivity Solution, visit http://www.capsuletech.com.

About the Capsule Neuron™ platform
The Capsule Neuron is Capsule’s Next Generation Bedside Platform for managing device connectivity. It is a touch screen device equipped with its own docking station that provides a universal view and status of connectivity for all devices connected to a patient, including devices that are connected locally to a Capsule Neuron docking station and devices that are networked via the hospitals’ wired or wireless LAN. And the Capsule Neuron provides the basis for an expanding set of solutions to enable positive patient association, improved bedside workflow and enhanced patient safety. For more information about the Capsule Neuron visit http://www.capsuletech.com/our-solution-capsule-neuron.htm.

About Capsule
For more than 12 years, Capsule has been the world’s leading, award-winning provider of solutions for medical device connectivity. The company has established market leadership through its FDA 510(k) cleared software and medical grade hardware products, its unique expertise in device protocols and firmware, and through its strong partnerships with major medical device manufacturers and HIS companies. Capsule’s solutions are proven, with over 617 installations at leading healthcare facilities worldwide and its technology is secure, with the largest installed device driver library. Furthermore, Capsule is continually recognized as the leader in the industry receiving the Frost & Sullivan Global Technology Leadership Award as well as the Deloitte Technology Fast 50 and Fast 500 EMEA Awards. And, with the introduction of the Capsule Neuron™ platform and Enterprise Connectivity Solution, Capsule will continue to be the leader, by working with our partners to develop and implement solutions that meet the short and long term patient safety needs of hospitals today. For more information about Capsule, visit the company’s Web site at http://www.capsuletech.com/ or contact the U.S. Marketing & Public Relations department at 978-482-2337.

Click here to see all recent news from this company

ROCKVILLE, MD–(Marketwire – July 13, 2010) –  MarketResearch.com has announced the addition of GBI Research’s new report “Surgical Equipment Market to 2016 – Emerging Economies to Provide Future Growth Opportunities,” to their collection of Surgical Equipment market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2718784.

GBI Research’s medical equipment report, “Surgical Equipment Market to 2016 – Emerging Economies to Provide Future Growth Opportunities” provides key data, information and analysis on the global surgical equipment market. This report on medical technologies provides data on market landscape, competitive landscape and market trends information on three surgical equipment market categories — Electrosurgical Devices, Hand Instruments and Surgical Sutures. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The global surgical equipment market has grown steadily during the last decade due to an increase in the number of hospitals and the rise in the number of surgical procedures performed both in the developed and emerging economies. In the future, the number of surgical procedures performed in the emerging economies is expected to grow at a faster rate than in developed economies, due to the higher economic growth forecasts for the emerging economies.

The surgical equipment market is highly competitive and fragmented with a healthy mix of international and local players. The addition of new hospitals and an increase in the number of operating rooms in existing hospitals in the emerging economies provide growth opportunities for both established players and new entrants.

Topics covered in the report include…

• Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Market size and company share data for three surgical equipment market categories – Electrosurgical Devices, Hand Instruments and Surgical Sutures.
• Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company share data for 2009.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within the surgical equipment market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Ethicon, Covidien, B. Braun, ERBE Elektromedizin, CONMED Corporation and Integra LifeSciences.

For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2718784.

Click here to see all recent news from this company

ALEXANDRIA, VA–(Marketwire – July 13, 2010) –  Summer means gardening, grilling, and swimming at the pool. Summer’s produce and expanded cooking options also mean the season is an opportunity to improve your eating habits. The American Diabetes Association announced today a completely revised online nutrition tool in English and Spanish to help you get ready for the season: MyFoodAdvisor™ (www.diabetes.org/MyFoodAdvisor).

The award-winning MyFoodAdvisor has new and expanded features that allow people to track their daily meals, substitute healthier alternatives in recipes or on the plate, and browse recipes. People with diabetes, heart disease, kidney disease, high blood pressure, high cholesterol and those looking to lose weight can use MyFoodAdvisor to find nutrition information on calories, carbohydrates, sodium, fat and cholesterol.

“You would be surprised to see how small substitutions at meal time can make a real difference in your health,” commented Christine Tobin, CDE, President, Health Care & Education, American Diabetes Association. “MyFoodAdvisor can set you up for success by showing you healthy alternatives, tracking what you eat and helping create goals. Losing 10 or 15 pounds can help stop diabetes by preventing or delaying type 2 diabetes or diabetes complications.”

Join American Diabetes Association’s Director of Nutrition and Clinical Affairs Stephanie Dunbar, MPH, RD, and USA Today’s Medical Reporter Mary Brophy Marcus to discuss healthy eating and using the completely revised MyFoodAdvisor during a Twitter Chat on Thursday, July 15, at 2 p.m. ET, at @AmDiabetesChat and #ADA_USAT.

New features include:

• Track It – You can create your own goals for calories, carbohydrate, sodium, saturated fat and fiber and compare what you currently are eating to what you want to be eating. This analysis allows you to make healthier options to lower sodium or saturated fat intake or to keep your carbohydrate intake consistent from day to day.
• Spanish Version – The entire web site is now available in Spanish. The prevalence of diabetes is 2 to 4 times higher among Hispanics/Latinos.

Updated features include:

• Healthy Alternative – This feature, unique to MyFoodAdvisor™, allows you to search for healthier foods. For example, searching for a healthier alternative to ground beef for your favorite burger recipe would provide choices for other ground meat products like turkey or even vegetable-based meat alternatives. The algorithm, based on recent research, takes into account 13 different nutrients to recommend the best alternatives based on your selections.
• Recipe Analysis – Analyze your favorite recipes with our Create Dish functionality. You can request healthier options for all of your recipe ingredients to make your old favorite a healthier favorite. Your own recipes can be saved in your recipe box and imported into the tracking it tool, and ingredients added to a shopping list.
• Create Dish – The portion sizes have been expanded to meet your preferences for using simple cooking measurements.
• Simpler Navigation – The new version allows you to better search and compare food options.

“For people with diabetes and their caregivers, one of MyFoodAdvisor’s useful features remains that serving sizes are based on 15 grams of carbohydrate, which makes it easier to count carbs. There is also information on phosphorus and potassium, two important nutrients to watch for people with kidney disease,” commented Tobin. “But MyFoodAdvisor can help anyone looking to make smart food choices this summer.”

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

id=”nav_links”>

ALEXANDRIA, VA–(Marketwire – July 13, 2010) – Prepararse para el verano significa sembrar
los jardines, limpiar el asador y salir a comprar trajes de baño. Los
productos del verano y las opciones para cocinar también significan que la
temporada es una oportunidad para mejorar sus hábitos alimenticios. La
Asociación Americana de la Diabetes anunció hoy sobre una herramienta en
línea de nutrición en español y en inglés que le ayudará a prepararse para
la temporada.: MiConsejerodeComida™ http://tracker.diabetes.org/es/.

MiConsejerodeComida tiene características nuevas y mejoradas que le
permitirán a las personas a mantener un registro de sus comidas diarias,
sustituir alternativas más saludables para recetas o en el plato. Las
personas con diabetes, enfermedades cardiacas, enfermedad renal, alta
presión arterial, alto colesterol y aquellas personas que quieren bajar de
peso pueden utilizar MiConsejerodeComida para encontrar información
nutricional sobre calorías, carbohidratos, sodio, grasa y colesterol.

“Hacer pequeños cambios al tiempo de la comida puede tener un impacto
positivo en su salud,” comentó Lorena Drago, RD, CDE, voluntaria de la
Asociación Americana de la Diabetes. “MiConsejerodeComida le puede enseñar
hacer alternativas saludables, crear metas y registrar lo que come. Si
pierde solamente 10 o 15 libras, usted puede ponerle alto a la diabetes al
prevenir o retrasar la diabetes tipo 2 o sus complicaciones…”

Las características nuevas incluyen:

• Versión en español – Todo el sitio web está disponible ahora en
  español. La prevalencia de la diabetes es de 2 a 4 veces más alta entre
  los hispanos/latinos.
• Regístrelo – Usted puede crear sus metas para calorías,
  carbohidratos, sodio, grasa saturada y fibra y compararlas con lo que
  actualmente está comiendo y lo que quisiera comer. Este análisis le permite
  hacer opciones más saludables para reducir el consume de sodio y grasa
  saturada o para mantener su consumo de carbohidratos consecuente en el día
  a día.

Las características actualizadas incluyen:

• Alternativa saludable – Esta característica, exclusiva a
  MiConsejerodeComida™, le permite buscar comidas más saludables. Por
  ejemplo, si busca una alternativa más saludable para la carne de res
  molida para su receta favorita de hamburguesa, le proporcionaría otras
  opciones de carne molida tales como, pavo molido o alternativas
  vegetarianas. El algoritmo, que es basado en investigaciones recientes,
  toma en cuenta 13 nutrientes diferentes para recomendar la mejor
  alternativa basándose en sus selecciones.
• Análisis de recetas – Analice sus recetas favoritas con nuestra
  función de Crear un plato. Usted puede solicitar opciones más saludables
  para los ingredientes de su receta para hacer que un viejo favorito sea un
  favorito saludable. Sus propias recetas pueden ser guardadas en su
  recetario e importadas a la herramienta de registro y los ingredientes
  pueden ser agregados a su lista de compras.
• Crear un plato – Los tamaños de las porciones han sido
  incrementadas para reunir sus preferencias al utilizar medidas simples de
  cocina.
• Navegación simple – Esto le permite buscar y comparar opciones
  de comidas con más facilidad.

“Los tamaños de las porciones en MiConsejerodeComida son basadas en 15
gramos de carbohidratos, lo cual hace que sea más fácil para las personas
con diabetes y sus cuidadores a contar carbohidratos. MiConsejerodeComida
también tiene información sobre fósforo y potasio, 2 nutrientes importantes
que se deben vigilar para las personas con enfermedad renal, comentó Lorena
Drago. “Sin importar para qué, MiConsejerodeComida puede ayudar a cualquier
persona a prepararse para el verano al enseñarle como hacer mejores
opciones de comida.”

La Asociación Americana de la Diabetes es líder en la lucha para ponerle
alto a la diabetes y sus consecuencias fatales y lucha por las personas
afectadas por esa enfermedad. La Asociación financia la investigación a fin
de prevenir, curar y controlar la diabetes; ofrece servicios para cientos
de comunidades; suministra información objetiva y verosímil; y da voz a
aquellas personas privadas de sus derechos como consecuencia de la
diabetes. La Asociación se fundó en 1940. Nuestra misión es prevenir y
curar la diabetes, así como mejorar la vida de todas las personas afectadas
por esa enfermedad. Para más información llamar al 1-800-DIABETES
(342-2383) o visitar www.portufamilia.org. Información sobre ambas fuentes
se encuentra disponible en inglés o en español.

SALT LAKE CITY, UT–(Marketwire – July 13, 2010) –  AdvancedMD® Software, Inc., the leader in all-in-one, web-based practice management, Electronic Health Record (EHR), and billing applications for medical practices and medical billing services, today announced that Physicians Resource Network, Inc. (PRN) became an AdvancedMD billing partner in March, and achieved AdvancedBiller™ status in July, by adding 17 providers to the AdvancedMD platform within a four month period, with six of those providers on the AdvancedMD EHR clinical package.

PRN, using the automated, integrated AdvancedMD Software-as-a-Service (SaaS) platform, is able to eliminate manual processes between the client practice and the PRN billing center, enabling the company to reduce staff required to service a client practice by approximately 30 to 60 percent. “With AdvancedMD as our foundation,” said Frances Holinda, president of Physicians Resource Network, “we are able to offer our clients a complete solution to deliver everything they need to stay current under healthcare reform. It’s all there, whether it’s online charges, integrated EHR or automated reporting, we can accommodate virtually any need. AdvancedMD is our power tool, enabling me to consult with our clients and maximize their revenue.”

PRN, founded in 1993, is based in Ocean, N.J. The company supports 25 providers who practice primarily in nephrology, cardiology and various surgery practices. The firm offers a range of practice services, including demographics data entry, charge entry, charge submission, payment posting, secondary insurance claims submission, appeals follow up, patient statements and patient follow up. “We pretty much handle everything up to the point of sending out collection letters,” said Holinda, who has an MBA in Health Care Management and is a member of HBMA. “I had enough experience in billing to know what I needed and to know that what I saw in AdvancedMD was exactly what I needed.”

Previously Holinda ran her business on a Unix-based, client/server platform, located on her premises. Many of the processes she has been able to automate using AdvancedMD were manual processes under the older system. In order for her clients to link to the Unix system, they had to install complicated VPNs. Additionally, someone on her staff was responsible for managing regular data backups. “Comparing what my office could provide in terms of redundancy, automated backups and bandwidth into the data center, to what AdvancedMD can provide, my business simply could not make the kind of IT investments that AdvancedMD has made in its enterprise class data center,” she added.

Since her business is physician billing, the main concern Holinda had when selecting a new billing platform were the revenue cycle management tools. “The EHR capabilities were a bonus,” said Holinda. “The fact that the EHR is so good means I can offer that clinical product to my physicians with confidence. Plus, if they prefer a different EHR, AdvancedMD gives me the option of interfacing to external products. I have all the tools I need to do their billing. The physicians have choices!”

Bill Stone, vice president and general manager of the AdvancedMD Billing Services Program, said: “Physicians Resource Network is an excellent example of the kind of experienced, proven billing service company that the AdvancedBiller program is attracting. Not only does our technology enable these seasoned business managers to become more efficient in servicing their client base, the platform offers a range of clinical and front office tools that make the practice more efficient. As a vendor that does not compete with our billing services partners, AdvancedMD is wholly focused on helping our AdvancedBiller partners grow and become more profitable.”

Resources:

• For additional background on Physicians Resource Network, read the case study.

• For more information about the AdvancedBiller program, visit www.advancedbiller.com.

About Physicians Resource Network, Inc.

PRN, founded in 1993, is based in Ocean, N.J. The company supports 25 providers who practice primarily in nephrology, cardiology and various surgery practices. The firm offers a range of practice services, including demographics data entry, charge entry, charge submission, payment posting, secondary insurance claims submission, appeals follow up, patient statements and patient follow up. For more information, visit: http://www.saasmedicalbilling.com/

About AdvancedMD Software
AdvancedMD provides a market leading Software-as-a-Service (SaaS) electronic health record (EHR) and practice management (PM) software platform delivered to more than 10,000 providers and 300 medical billing service providers nationwide. As a complete Medical Practice Optimization solution, the product combines the clinical with the financial to improve workflow and revenue capture. The AdvancedMD solution includes a certified EHR, patient portal, scheduling, electronic eligibility verification, electronic prescribing, and mobile access capabilities for the practice, and sophisticated, efficient claims processing, denial tracking and revenue management for the billing professional. Processing more than 1M claims per month through its clearinghouse, the company is able to identify payer rule changes quickly and continuously adjust the software to reflect those changes, yielding first-pass claim acceptance rates of 95 percent or better, compared to the national average of 70 percent. For more information, please visit www.advancedmd.com.

TAMARAC, FL–(Marketwire – July 13, 2010) –  AcuMedSpa Holdings, Inc. (PINKSHEETS: AMSZ), a provider of Medical Aesthetic, Spa and Acupuncture services, announced it has entered into talks to make two separate acquisitions. One of the companies is domestic and the other international.

The domestic acquisition has a substantial nationwide footprint which when completed will open up several new markets for AcuMedSpa. The international acquisition is progressing well but is slightly behind the domestic one in terms of expected timeframe for finalization. When completed, it will provide AcuMedSpa with a global presence in the spa industry.

The company is also making headway with its project to open AcuMedSpa in Poland. Completion will take a little longer due to some of the legal aspects and complexities involved in dealing with the E.U.

The previous sale of the company’s “Spa within a Practice” subsidiary in the month of May, has cleared nearly half a million dollars in debt off the books and will allow AcuMedSpa to realize positive earnings in 2010. When originally stating its revenue and earnings expectations for the current year, the company took into consideration its pending acquisitions, incorporated with its current business activities. Upon completion of these two key acquisitions the company expects to meet and exceed its previously stated 2010 projections.

“Over the past few months we have been working very hard to successfully improve current operations while reducing our liabilities,” stated AcuMedSpa Holdings President Gregory Antoine. “Our objective all along has been to expand our business two ways. First through the successful acquisition of spa and aesthetic practices, and second by opening new facilities in key markets.” Mr. Antoine further commented, “Our progress so far this year together with these acquisitions nearing completion puts us on pace to exceed our $2,000,000 net income goal for 2010.”

The company also announced that its wholesale health and beauty division, Consumer Care of America LLC, is on pace to exceed expectations. The focus of this division is high volume sales. More detailed information on Consumer Care of America will be provided in a future update.

Please follow our progress on twitter: http://twitter.com/acumedinc

For additional info please visit our website: http://www.acumedspa.com/

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements as a result of various factors, and other risks. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and AcuMedSpa Holdings, Inc. takes no obligation to update such statements.

ALEXANDRIA, VA–(Marketwire – July 12, 2010) –  Over the past several weeks reports have again surfaced regarding the cardiovascular safety of the diabetes drug rosiglitazone. While some analyses have suggested an increased cardiovascular risk with use of rosiglitazone, others have not provided any evidence of such an association. To help patients and physicians make informed decisions regarding use of rosiglitazone, the American Association of Clinical Endocrinologists (AACE), the American Diabetes Association and The Endocrine Society issued a joint statement with recommendations:
http://www.diabetes.org/for-media/2010/ada_aace_endo.html

The statement recommends that patients should continue taking all currently prescribed medications unless instructed otherwise by their health care provider. Stopping diabetes medications can result in higher levels of blood glucose that may cause serious short term health problems and could increase the risk of diabetes-related complications in the long term.

The joint statement also informs patients that regardless of the opinion and decisions on rosiglitazone, there are numerous drugs available to maintain glucose control in people with type 2 diabetes. Patients should discuss these options with their health care providers.

In the next few days (July 13-14) the U.S. Food and Drug Administration (FDA) is expected to complete the Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee. This committee was convened to evaluate the scientific research available on the safety of rosiglitazone and then issue its decision on how the drug should or should not be used. The joint statement recommends that until further clarification is provided by the FDA, the decision whether or not to use any medication must remain that of the treating provider in direct discussion with the individual patient.

Following any decision from the FDA, AACE, the American Diabetes Association and The Endocrine Society will provide detailed information interpreting FDA action for both health care professionals and patients with diabetes.

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Founded in 1916, The Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society’s membership consists of over 14,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at www.endo-society.org.

AACE is a professional medical organization with more than 6,000 members in the United States and 91 other countries. AACE members are physicians who specialize in endocrinology, diabetes, and metabolism. For more information about AACE, visit our Web site at www.aace.com, become a fan on Facebook at www.facebook.com/theaace or follow us on Twitter at www.twitter.com/theaace.

id=”nav_links”>

WINCHESTER, CA–(Marketwire – July 12, 2010) –  Michael Cooper is a Vietnam veteran from Tampa, Florida. Having served in the U.S. Army from 1970-73 as a helicopter flight engineer, Cooper saw more than his share of combat. “My father was a WWII Army veteran so the decision to serve my country came easily,” says Cooper. He also knows firsthand what it’s like to be hospitalized, adding, “It’s the boredom that’s the worst. All the free time you have between appointments is the hardest to deal with.” Cooper recalls coming out of surgery and the first thing he was asked was if he would like to assemble a craft kit. The individual offering the kit was a Craft Care Specialist (CCS), employed by national nonprofit Help Hospitalized Veterans (HHV) and stationed at the Tampa VA medical center.

As a patient, Cooper went on to enjoy working with many of the arts & crafts provided by HHV and later decided to volunteer in the craft clinic. His help with HHV craft kits has now come full-circle, as Cooper himself is now employed as the CCS at the Tampa VA Medical Center. “I never dreamed I’d have this job. It’s such a joy to be of service to other veterans. It’s particularly rewarding to help those who are feeling down. Every day I get to witness new sparks of life. For some veterans, work on the arts and crafts brings about improvement of fine and gross motor skills, while others enjoy increased attention spans. Cognitive improvements have even been seen in brain injury patients. Every week somebody’s life is changed,” adds Cooper. “We utilize the HHV kits throughout the hospital and favorites include model cars and motorcycles, leather and sun catchers.”

“Perhaps the most intriguing benefit the arts & crafts provide is the impact they’re having in the pain care clinic,” said Cooper. “You wouldn’t believe it, but people with significant pain find their tolerance level increases while working on the arts & crafts. It’s as if the diversion tricks the brain and for that period of time the patient is able to find relief and comfort.”

HHV is the largest supplier of free therapeutic arts and crafts kits to our nation’s VA and military hospitals. Since the organization was founded in 1971, over 25 million therapeutic arts and crafts kits have been donated to hospitalized veterans absolutely free of charge with over $3.5 million worth donated to the Tampa VA medical center since their inception to the program.

For more information on HHV programs and services please visit www.hhv.org or call toll-free 1-888-567-VETS.

Documents and/or Photos available for this release:
PDF_of_release

To view supporting documents and/or photos, go to www.enr-corp.com/pressroom and enter Release ID: 263241

MUNDELEIN, IL–(Marketwire – July 12, 2010) –  Only 40 percent of infection control professionals indicated that more than three-quarters of the nurses at their facility were applying the CDC’s CAUTI prevention guidelines, and less than half reported that their facilities were conducting annual education and training on alternatives to catheterization, according to a survey conducted today. The survey of infection control professionals was conducted at a breakfast forum on prevention of catheter-associated urinary tract infections (CAUTI), sponsored by Medline Industries, Inc. in conjunction with the Association for Professionals in Infection Control and Epidemiology (APIC) Annual Scientific Meeting being held in New Orleans, LA. 

Additionally, while nearly 80 percent of attendees cited CAUTI prevention as one of their facility’s top priorities this year, almost half reported that they do not have an annual competency validation process for staff to assure that they are competent in CAUTI prevention measures and inserting Foley catheters.

“These results reaffirm the need for industry vendors to partner with healthcare providers on a comprehensive system that incorporates proper procedures and social behaviors that are easy to adopt in everyday practice,” said Lorri Downs, R.N., B.S.N., M.S., C.I.C., vice president of Infection Prevention at Medline and a board certified infection preventionist. “Reducing CAUTI rates is not just about taking precautions. We must transfer knowledge to the bedside clinician in new ways such as through interactive learning and online competency validation courses to ensure industry guidelines become the standard course of care.”

That was the experience at Arkansas Methodist Medical Center, located in Paragould, AR. The organization did not have a formal education program in CAUTI prevention prior to implementing Medline’s ERASE CAUTI program, but has seen significant results since it began using the evidence-based program three months ago.

“Since we’ve been using the ERASE CAUTI program, our facility has experienced an almost 20 percent decrease in our CAUTI rate and a more than 10 percent decrease in the number of Foley catheters placed,” said Lisa Bridges, infection preventionist at Arkansas Methodist Medical Center. “I believe the decreases will be even more in the coming months. We are still in the process of educating our staff on following the guidelines. Having the checklist on the outer packaging helps us to make sure that catheterization is an appropriate option for the patient.”

Medline is highlighting evidence-based CAUTI prevention practices and products at this year’s APIC Congress (booth #1907). During the three-day exhibition, Medline is demonstrating its ERASE CAUTI program, a revolutionary new approach to managing catheters and reducing CAUTI. Based on the same criteria the CDC used in developing their new CAUTI prevention guidelines, the ground-breaking ERASE CAUTI program features a reengineered one-layered catheter tray coupled with an evidence-based clinical education program.

As part of its presentation, the Medline clinical team is conducting a series of live, multimedia overviews of its cutting edge competency validation tools for assessing and sustaining staff results. The interactive competency programs are available to staff anytime via Medline University, Medline’s online education resource, and can be easily incorporated into the annual skills competency program for a facility’s nursing staff.

CAUTI is one of the most common healthcare-associated infections, not only comprising 40 percent of all institutionally acquired infections, but also eight percent of infections in the home care setting. Studies show that one in four patients receives an indwelling urinary catheter at some point during their hospital stay and up to 50 percent of these catheters are placed unnecessarily.

Additional information on the ERASE CAUTI program is available on Medline’s website at www.medline.com/erase.

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

SILVER SPRING, MD–(Marketwire – July 12, 2010) –  The Association of Public Health Laboratories (APHL) has received an award for $16.3 million from the Centers for Disease Control and Prevention (CDC) to enhance the work of public health laboratories in the US and abroad. The award continues an APHL-CDC collaboration of over 20 years in support of governmental health laboratories.

Funded as a five-year cooperative agreement, the award will assist APHL to promote quality public health laboratory practice, strengthen the public health laboratory system and develop a well-trained workforce. 

“APHL is committed to improving health outcomes by strengthening the capacity of public health laboratories both nationally and globally,” said Dr. Patrick Luedtke, director of the Unified State Laboratories in Utah and APHL president. “Public health laboratories protect us against diseases, environmental hazards, natural disasters and other health threats. A stronger lab system means healthier people.”

APHL is a leader in development and implementation of public health laboratory practice, systems, policy and training. Members serve as laboratory first responders, protecting the public from diseases and environmental health hazards. 

The Association of Public Health Laboratories is a national non-profit located in Silver Spring, MD, that is dedicated to working with members to strengthen governmental laboratories with a public health mandate. By promoting effective programs and public policy, APHL strives to provide public health laboratories with the resources and infrastructure needed to protect the health of US residents and to prevent and control disease globally.

Click here to see all recent news from this company

WEST HARTFORD, CT–(Marketwire – July 12, 2010) –  ORLive, the vision of improving health, presents a live hip replacement surgery featuring the Continuum Acetabular System and the Fitmore Hip Stem from Zimmer. Earlier in the week ORLive will premiere an update to the Hepatocellular Carcinoma program presented by NewYork-Presbyterian, including information on living donor liver transplant options.

This week ORLive also invites you take part in the latest installment of the Virtual Brain Tumor Board, and to watch and learn from this month’s featured channel of no-visible-scar surgeries.

NEW ON ORLIVE

NEW VIDEO: Program Update: Hepatocellular Carcinoma – Living Donor Liver Transplant

Premieres Tuesday July 13 – In March of this year the Center for Liver Disease and Transplantation of NewYork-Presbyterian presented a special program that highlighted research findings on the diagnosis, treatment and survival rates of Hepatocellular Carcinoma (HCC), from. Now they’re updating this information with new segments on living donor kidney transplant.

HCC, the most common form of liver cancer, is diagnosed in about 24,100 people each year. Watch this webcast to learn more about the latest advances in the diagnosis and treatment of liver cancer.

Viewers will be able to interact and ask questions via the ORLive website. Learn more about this live video broadcast on ORLive.com.

LIVE SURGERY – The Anterior Supine Approach to Total Hip Arthroplasty

Live Wednesday, July 14, 2010, 7PM EDT

ORLive and Zimmer will present a live Total Hip Arthroplasty featuring the Continuum Acetabular System and the Fitmore Hip Stem. The surgery will be performed by Dr. Jonathan Yerasimides, University of Louisville Department of Orthopaedics, Louisville, KY and will be moderated by Dr. Hari Bezwada, University of Pennsylvania School of Medicine Department of Orthopaedic Surgery, Philadelphia, PA. The broadcast will last one hour and will show the entire surgical procedure. This opportunity allows for firsthand insight of the safe and effective implantation and surgical procedure involved with the Continuum Acetabular System and the Fitmore Hip Stem.

Viewers will be able to interact and ask questions via the ORLive website. Learn more about this program, and request a reminder on ORLive.com.

ORLIVE REFERRALS – Week of July 12, 2010

Each week ORLive highlights on-demand videos for our membership and visitors. 

No Visible Scar Surgery Referral: Advances in Laparoscopic Colorectal Surgery: Journey from HALS to NOTES from Covidien

CME Referral: Advances in Pancreatic Cancer Care from Thomas Jefferson University Hospital

Viewer’s Referral: Aortic Aneurysm Repair from Baptist Health Miami

HIGHLIGHTS

NOW ON-DEMAND – German Language Broadcast to Europe, Featuring ConforMIS iUni^® G2 Patient Specific Partial Knee Replacement System

Now Available On-Demand

Originally broadcast live from the University of Wuerzburg Orthopedic Center for Musculoskeletal Research, this video features a partial knee replacement surgery using the ConforMIS iUni G2 system. The broadcast featured Dr. Wolfgang Fitz of Brigham and Women’s Hospital, Dr. Ulrich Nöth and Dr. Maximilian Rudert, both of the University of Wuerzburg Orthopedic Center for Musculoskeletal Research, presenting and performing the surgery. Learn more about this broadcast, presented entirely in German, at http://www.orlive.com/conformis-inc-/videos/n-chste-generation-patienten-spezifischer-knieoberfl-chenersatz-mit-conformis-iuni-sup-/sup-g2-17-00-uhr-mez-1

Viewers are still able to interact and ask questions via the ORLive website. Learn more about this program, and request a reminder on ORLive.com.

NOW ON-DEMAND – Advances in Treating Pediatric Epilepsy

Now Available On-Demand

If a child’s seizures can’t be controlled with medications, surgery may be the solution. See how the Neurosurgical team at NewYork-Presbyterian Phyllis & David Komansky Center for Children’s Health is making advancements in epilepsy. Hosted by Philip Stieg, MD, PhD, and featuring Jeffrey Greenfield, MD, PhD, Samual Weinstein, MD, and Theodore Schwartz, MD, this program goes in depth into the latest surgical advancements and options for patients. 

Viewers of this video are invited to interact with the surgeons via the ORLive website, and to join the community and receive regular updates from the NewYork-Presbyterian Phyllis & David Komansky Center for Children’s Health on pediatric epilepsy.

SUPPLEMENTAL CONTENT – VOX ORLive

Explore robotic assisted mitral valve surgery with cardiac surgeon Dr. Lynn Seto in the current episode of VOX ORLive, an audio podcast featuring the latest advancements in medicine, surgery, and medical technology.

About ORLive

ORLive is the leading provider of video communication channels to the healthcare community. Working collaboratively with hospitals and device manufacturers, ORLive produces and distributes customized, interactive, video programs that demonstrate the latest advances in medicine, surgical techniques and product innovations. The ORLive broadcasting network provides an intimate look at over 650 live and on-demand surgeries to a global audience, streaming over 50,000 hours of programming each month. The ORLive network can be found on-line at www.ORLive.com.

id=”nav_links”>

ALISO VIEJO, CA–(Marketwire – July 12, 2010) –  CNS Response (OTCBB: CNSO) announces the appointment of Michael E. Darkoch as Executive Vice President and Chief Marketing Officer. In this role, Darkoch will assume all responsibility for the launch and commercialization of the Company’s flagship product, Referenced-EEG, including all marketing, business development and patient advocacy activities.

“Mike is a known quantity,” said CNS Response CEO George Carpenter. “In the world of pharmaceutical benefits, he understands what drives consumers, what payers pay for, and how to scale services around them. His industry expertise and payer relationships will be incredibly valuable as we introduce Referenced-EEG to a broader market. I’ve worked with Mike in three companies and his experience, skills and performance record will be crucial to our future success.”

Darkoch joins CNS Response with extensive executive experience at healthcare companies including Baxter International, CORE, Inc, and pharmaceutical benefits management firm Caremark Rx, where he grew sales from $100 million to $2.1 billion within five years, while achieving an industry record of 98 percent client retention for a two-year period. 

Prior to joining CNS Response, Darkoch held senior management positions with MedImpact Health Systems, a prescription benefit management firm in San Diego, where he successfully managed product development and increased new sales revenues 15 percent, market segment revenues by 40 percent and specialty products’ revenues by 35 percent. 

Darkoch commented, “One of the greatest challenges in the pharmaceutical arena is to understand how medications will impact patients differently, and mental disorders represent one of the largest opportunities where numerous medications have individualized outcomes.

“I believe Referenced-EEG may offer an important answer, helping physicians improve clinical outcomes for patients, and economic outcomes for us all. My goal is to establish the CNS Response brand and reputation quickly in this emerging area of personalized medicine.”

Darkoch holds a Bachelor of Science of Industrial Engineering from Lehigh University and Master of Science in Business from Southern Methodist University. He started his engineering and management career with Texas Instruments and Mobil Chemical Company, before moving into the healthcare and pharmaceutical sectors.

About CNS Response
Today, most physicians are able to base treatment on objective test data, such as EKGs, MRIs, blood tests, etc. Broadly speaking, such advances have not yet come to those physicians practicing psychiatry.

Referenced-EEG was developed by physicians to provide objective, personalized, statistical data on patient neurophysiology. In clinical trials, physicians using rEEG data have consistently achieved superior clinical results compared to physicians using trial and error pharmacotherapy.

The Company announced publication last week of results from its most recent clinical trial in The Journal of Psychiatric Research, in which physicians using Referenced-EEG (rEEG^®₎ had success rates reaching 65 percent for patients with treatment-resistant depression.

To read more about the benefits this patented technology provides physicians, patients and insurers, please visit the CNS Response website, www.cnsresponse.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties as set forth in the Company’s filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.

Click here to see all recent news from this company

NEW ORLEANS, LA–(Marketwire – July 12, 2010) –  Hand washing and frequent wiping of surfaces like counters and handrails are necessary elements in institutional infection-control protocols. Effective as these techniques are, however, they are labor intensive, not automated, and do nothing to counter airborne bacteria — one of the primary mechanisms for the spread of disease. With the introduction of Prolitec, Inc.’s aria™ air-sanitizing agent, assisted-living facilities, hospitals, medical offices, and other enclosed spaces finally have a means of addressing this critical gap in infection control.

Prolitec’s Aerobiology and Infection Control division unveiled the new aria™ system today at the annual conference of the Washington, D.C.-based Association for Professionals in Infection Control and Epidemiology, in New Orleans.

The aria™ air-sanitizing system, which won EPA registration in November 2009, uses newly patented Prolitec technology to generate an invisible “dry” vapor of a safe and effective air sanitizing agent. The vapor can be distributed within a space directly from a small wall-mounted appliance or indirectly through an air handler. The result is a uniformly distributed vapor compliant with OSHA air-contaminant restrictions for workplace inhalation — one that is non-damaging to materials and electronics, yet significantly decreases the numbers of viable airborne bacteria under relatively wide conditions of relative humidity and temperature.

“Bacteria and other microorganisms are frequently introduced into the air by actions such as sneezing and coughing. Once microorganisms are airborne they can be inhaled or can settle and contaminate surfaces,” noted Dr. Craig A. Kelly, a veteran Johns Hopkins University scientist and chief of Prolitec’s Aerobiology and Infection-Control unit. “The function of the aria™ system is to reduce the concentration of airborne bacteria in a continuous and automated manner, thereby reducing the likelihood of inhalation or surface-settling of viable microorganisms.”

“An important feature of aria™ is that it is fully automated and works 24 hours a day, seven days a week without any human intervention,” noted Richard Weening, CEO of Milwaukee-based Prolitec. “The aria™ system can safely and effectively reduce background levels of airborne bacteria to establish the foundation of a successful infection-control protocol. It is the one part of the program that will always be 100% compliant.”

Dr. Kelly added: “Amid heightened awareness of disease transmission by airborne microorganisms, aria™ provides a critical tool for the infection-control professional to address airborne bacteria in a way that was not previously available. That can translate into a greater sense of safety and well-being for patients, residents, caregivers and visitors alike.”

About Prolitec
Prolitec (www.prolitec.com) develops and deploys air-treatment and air care technologies, including odor control, ambient scenting, aromatherapy and the use of scent as a medium of communication. Clients include assisted-living facilities, hotels, casinos, retailers and other commercial organizations in the United States and around the world. Prolitec’s Aerobiology and Infection Control Unit is developing interior air and surface systems to inhibit disease transmission.

NOTE TO EDITORS: Photos are available from Parness & Associates

ROCKVILLE, MD–(Marketwire – July 12, 2010) –  MarketResearch.com has announced the addition of GlobalData’s new report “HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016,” to their collection of Diseases & Conditions market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2709528.

GlobalData’s report, “HIV/AIDS – Pipeline Assessment and Market Forecasts to 2016” provides an essential source of information and analysis on the global HIV/AIDS market. The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insights on the prevalent competitive landscape and the companies expected to significantly alter the market landscape. Most importantly, the report provides valuable insights on the pipeline products within the global HIV/AIDS sector. GlobalData estimated the HIV/AIDS market was worth $12 billion in 2009. It is forecast to grow at a Compound Annual Growth Rate (CAGR) of 2% for the next seven years to reach $13.7 billion by 2016. The global Human Immunodeficiency Virus (HIV) infection market will continue to grow between 2009 and 2016 at a slower rate due to a series of patent expiries during this period. The growth rate is likely to decline from 2012 onwards due to the impact of the patent expiry of key drugs. The market is characterized by a high unmet need of drugs which can cure the disease. Highly Active Antiretroviral Therapy (HAART) which requires patients to take different classes of drugs has however succeeded in achieving near zero levels of HIV in infected people. Increased uptake of HAART and increasing awareness (which leads to increased treatment seeking) will drive the market. The pipeline for HIV is strong and consists of more than 261 molecules currently in development for various disease segments.

Topics covered in the report include…

• Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016.
• Pipeline analysis data providing a split across phases by mechanism of action, and the emerging trends. The key classes of mechanism of action include HIV vaccines, Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), CCR5 receptor antagonists, HIV integrase inhibitors, Nucleoside analogues, Viral entry inhibitors, Maturation inhibitors and Fusion Inhibitors.
• Analysis of the current and future market competition in the global HIV/AIDS market. The key market players covered Boehring Ingelheim, Achillion Pharmaceuticals, GlaxoSmithKline, Incyte and Pharmasset, Shire Pharmaceuticals and Tibotec Virco
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
• A strategic competitor assessment, market characterization, unmet needs and implications for the future HIV/AIDS market.

For more information visit http://www.marketresearch.com/product/display.asp?ProductID=2709528.

Click here to see all recent news from this company

LOS ANGELES, CA–(Marketwire – July 12, 2010) –  MMRGlobal, Inc. (OTCBB: MMRF) (www.mymedicalrecords.com) today announced it has entered into an agreement with Benchmark Financial Groups to help fund the Company’s deployment of MMRPro, including the specially configured Kodak 520MDPro scanner designed exclusively for distribution with the MMRPro system. MMRPro is the Company’s complete end-to-end electronic document and patient record chart management system designed to provide healthcare professionals with an easy-to-use and cost-effective solution to digitize, store, retrieve and electronically share medical records (www.mmrmdvideos.com).

Robert H. Lorsch, MMRGlobal Chairman and Chief Executive Officer, said, “This credit facility is designed to ensure the Company can maintain sufficient inventories of Kodak 520MDPro scanners and Capture Pro software to support Kodak’s domestic and international sales teams, the recently announced sales agreement with National Payment Providers (NPP), and the Company’s direct sales efforts without the need to use the Company’s existing credit line with The RHL Group or its pending equity line. NPP currently sells billing services to more than 168,000 healthcare clients and will offer MMRPro as part of its services.” 

“This program will also provide the resources necessary to expand the Company’s training, installation and customer support personnel for MMRPro Services,” Lorsch added.

MMRGlobal, Inc. is headquartered in Los Angeles, California. In addition to the MMRPro solution for healthcare professionals, the Company’s suite of information technology products includes the MyMedicalRecords Personal Health Record and MyEsafeDepositBox electronic vault. To view demonstrations of the Company’s products, visit www.mmrtheatre.com. 

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMRGlobal, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheatre.com.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, the risk the Company’s products are not adopted or viewed favorably by the healthcare community, risks related to the current uncertainty and instability in financial and lending markets, timing and volume of sales and installations, length of sales cycles and the installation process, market acceptance of new product introductions, ability to establish and maintain strategic relationships, ability to identify and integrate acquisitions, relationships with licensees, competitive product offerings and promotions, compliance with and changes in government laws and regulations and future changes and initiatives in the healthcare industry, undetected errors in our products, risks related to third party vendors, risks related to obtaining and integrating third-party licensed technology, acceptance of the Company’s marketing and promotional campaigns, risks related to a security breach by third parties, maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets, uncertainties associated with doing business internationally across borders and territories, and additional risks discussed in the Company’s filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. 

Click here to see all recent news from this company

SCOTTSDALE, AZ–(Marketwire – July 12, 2010) –  Rural/Metro Corporation (NASDAQ: RURL) announced today that senior human resources executive Maureen Thompson, 49, has joined the Company to lead strategic and corporate human resources throughout the enterprise.

Michael P. DiMino, President and Chief Executive Officer, said, “Maureen is a highly regarded human resources leader with an extensive record of strategic and operational experience in large organizations across a variety of industries. She is a results-driven, operationally motivated leader who is adept at communication and collaboration at every level of an organization. We are very pleased to welcome her to Rural/Metro.”

In her role at Rural/Metro, Ms. Thompson will be responsible for all human resources leadership, strategy and direction, including employee relations, training, recruiting, compensation, benefits, organizational management, and policy and procedure development. She will report directly to the CEO.

Ms. Thompson has a demonstrated track record of working with large consumer product and retail organizations, including Retail HR Strategic Business Partner for The Goodyear Tire and Rubber Company, the world’s largest tire company with annual sales of $18 billion, from 2006 to 2009. From 2002 to 2006, she was Vice President of Human Resources for LESCO Inc., a $585 million public company that was the nation’s largest distributor of landscape and lawn care products (now an operating company of John Deere). Prior to that, Ms. Thompson was Vice President of Human Resources for Alamo Local Market Division, a division of ANC Retail Corporation, from 2000 to 2002.

“I am excited about this great opportunity and look forward to building a best-in-class human resources team that focuses on both strategic and tactical solutions that will support Rural/Metro’s organizational growth in the future,” Ms. Thompson said.

About Rural/Metro

Rural/Metro Corporation provides emergency and non-emergency ambulance services and private fire protection services in 20 states and approximately 400 communities throughout the United States. For more information, visit the Company’s web site at www.ruralmetro.com.

SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS

The foregoing reflects the Company’s views about its future financial condition, performance and other matters that constitute “forward-looking” statements as such term is defined by the federal securities laws. Many of these statements can be found by looking for words such as “believe,” “anticipate,” “expect,” “plan,” “intend,” “may,” “should,” “will likely result,” “continue,” “estimate,” “project,” “goals,” or similar words used herein in connection with any discussions of future operating or financial performance or business prospects. We may also make forward-looking statements in our earnings reports filed with the Securities and Exchange Commission, earnings calls and other investor communications. These forward-looking statements are subject to the safe harbor protection provided by federal securities laws. These forward-looking statements are subject to numerous risks, uncertainties and assumptions, including those relating to the Company’s future business prospects, future growth plans and future operating results. In addition, the Company may face risks and uncertainties related to other factors that are listed in its periodic reports filed under the Securities Exchange Act. Although the Company believes the expectations reflected in its forward-looking statements are based upon reasonable assumptions, because the statements are subject to risks and uncertainties, the Company can give no assurance that its expectations will be attained or that actual developments and results will not materially differ from those expressed or implied by the forward-looking statements. Readers are cautioned not to place undue reliance on the statements, which speak only as of the date hereof. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.

(RURL/G)

RIVERSIDE, CA–(Marketwire – July 12, 2010) – ONRAD Inc., a leader in radiology solutions, including teleradiology, on-site coverage, and technology services, is proud to announce the launch of their new website, which makes it easier for users to navigate and find information on all the company’s radiology solutions. “The new site is a better reflection of ONRAD and provides all the important information about our service offerings,” said Ryan Pahler, Director of Sales and Marketing. The site includes full information on ONRAD’s newest service offerings including on-site radiology coverage, which is available to new and current customers. Users will also find additional information on new Subspecialty Teleradiology interpretation services for Orthopedic and Neurology groups on top of the teleradiology services that they already provide. 

The ONRAD blog (onradinc.wordpress.com) and Twitter (twitter.com/onradnews) pages are also live. “Our goal for the social media pages is to create a space where industry leaders can share information and ideas,” says Pahler, “they’re not intended to be another billboard for our advertising messages, but a place where we can build a community to support others in the industry.” 

“2010 has been a record year so far for ONRAD,” said Brian Phelan, ONRAD’s President and COO. “The foundation of our success has been our ability to address the needs of the radiology community through our flexibility and customizable service offerings,” said Phelan in reference of the company’s recent headlines including the acquisition of a subspecialty radiology provider, and introduction of additional service offerings that include billing operations and on-site staffing solutions. “ONRAD began as a traditional teleradiology provider, but has evolved into a true radiology solutions company.”

As a partner, ONRAD provides more than just teleradiology interpretations. The executive team develops strategies to help customers be more competitive in their local communities. ONRAD’s unique solutions are customized for each customer to help increase profitability and improve patient care.

For more information on ONRAD Inc. visit www.onradinc.com

To read more on this topic, visit: http://www.onradinc.com/?page_id=1818

About ONRAD Inc:

ONRAD is a full service physician-owned radiology provider offering customized radiology services including professional staffing, teleradiology solutions, and technology services. As a partner, ONRAD helps customers become more competitive in their local markets by complementing and expanding the radiology services already in place or providing a comprehensive solution. 

Click here to see all recent news from this company

OXFORD, UK–(Marketwire – July 12, 2010) –  Mirada Medical Limited (“Mirada” or “the Company”)

Oxford, UK and Ohio, US, 12 July 2010: Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, announced today that Karsten Damgaard-Iversen has joined the Board of the Company as Non-Executive Chairman. 

Karsten Damgaard-Iversen is an internationally accomplished business professional with more than 30 years global experience of working within the healthcare imaging industry. He is a proven leader with a successful track record in operational and strategic management positions within small, medium and large medical imaging and healthcare technology companies. Mr. Damgaard-Iversen, aged 54, combines strong business acumen with in-depth technical and medical knowledge and has served in executive positions such as Managing Director and Chief Group Executive of Toshiba Medical Systems Europe BV, Managing Director of Toshiba Medical Systems (UK) Ltd., Vice President of International Operations of Fisher Imaging Corporation and Director of Sales & Marketing of Storz Medical AG. Mr. Damgaard-Iversen has also been a direct contributor to the invention and development of specific laser and x-ray based medical products. He holds an MBA from Emory University and a BSc in electronic engineering from Copenhagen University College.

In addition to his role as Chairman at Mirada Medical, Mr. Damgaard-Iversen is the founder and director of Disease Control Innovations Medical BV, a Dutch company engaged in product and EU business development of new medical technology that encompass innovative solutions to disease management and diagnosis. DCI Medical currently supports SonoCine Corporation, a privately held US inventor of automated whole breast ultrasound (AWBU) for screen detection of mammograhically occult breast cancer, and US quoted Imaging Diagnostic Systems, a pioneer in laser optical imaging systems.

Commenting on the appointment of the new Chairman, Hugh Bettesworth, CEO of Mirada Medical, said: “I am delighted that Karsten has chosen to join Mirada Medical as Chairman and that we have been able to attract such international talent from the medical imaging industry to our Board. Karsten’s experience in product development, together with his strategic and operational leadership, will provide Mirada with excellent guidance and steering as we continue to grow and prosper in the global oncology imaging marketplace.”

Commenting on his appointment as Chairman of the Board of Mirada Medical, Mr. Damgaard-Iversen said: “I am extremely impressed by Mirada’s innovative solutions for oncology disease management and cross modality decision support systems and I hope to be able to make a significant contribution to the growth and development of the Company. I look forward to working with the team at Mirada and applying my experience and know-how from the medical imaging arena to guide and support the future success of Mirada.” 

About Mirada Medical

Mirada Medical Limited develops internationally recognised medical imaging analysis applications that provide clinicians with an enhanced software package for the quantification of images, typically used in cancer diagnosis and treatment response assessment. Mirada Medical’s technology has broad applicability across nuclear medicine, diagnostic radiology, radiation oncology and medical oncology. Mirada Medical also markets products in neurology and cardiology. Mirada specialises in offering comprehensive and quantifiable analysis for the diagnosis, staging, treatment planning and assessment of treatment response in oncology. Mirada’s advanced technology allows medical images acquired using MRI, CT, SPECT or PET scanners to be combined into one, a process known as image fusion. Image fusion is useful in clinical interpretation as it allows different qualities of information to be combined into a single picture, for example, functional information such as metabolic activity, to be combined with anatomical information showing the precise location of pathology relative to bones and organs. This provides clinical users with a more complete picture, thereby improving the quality of information available when managing a patient’s condition. Mirada’s products are designed to support the comparison of multi-modal images acquired over any number of follow up visits by the patient, making them particularly well suited to the analysis of treatment response in longer term treatment plans such as those typical when treating cancer.

Mirada Medical was formed out of Oxford University by Professor Sir Michael Brady, one of the world’s leading medical imaging scientists. The Company is ISO 13485 certified and its technology has been supplied globally to customers in countries including the US, Japan, and Europe since 2001. Mirada’s products are sold by Mirada but also by major healthcare players such as McKesson, Siemens, Sectra, Carestream and Vital Images.

The Mirada team is a combination of world class scientists and exceptional engineers sourced from both Oxford University and leading blue-chip companies. For more information about Mirada Medical, please visit www.mirada-medical.com.